#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic intracranial hypertension Hepatitis D Non-small cell lung cancer KBG syndrome Colorectal adenocarcinoma Infantile spasms Mitochondrial encephalomyopathy Familial haemophagocytic lymphohistiocytosis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Sarcoma Muscular dystrophy Bronchiectasis Fatty acid oxidation disorder Lung adenocarcinoma Anti-neutrophil cytoplasmic antibody positive vasculitis More trials…

    Learn about Rare Diseases

    Netherton’s syndrome Primary mediastinal large B-cell lymphoma – Basic Information Acquired haemophilia – Basic Information Pelizaeus-Merzbacher disease – Diagnostics Cholangitis sclerosing – Diagnostics Mast cell activation syndrome – Treatment Waldenstrom’s macroglobulinaemia refractory – Diagnostics Hypereosinophilic syndrome – Trials in Disease X-linked lymphoproliferative syndrome – Life with Disease Toxic epidermal necrolysis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nadroparin Calcium Mercaptopurine Mitazalimab Ptc518 Rtp-026 Sodium HRS 9531 Sodium Hypochlorite Ucart20X22 Cilastatin Sodium Cangrelor Tetrasodium Azithromycin Levothyroxine Upacicalcet Sodium Hydrate Seladelpar Clofazimine Xenon (129Xe) Islatravir Lamotrigine Paliperidone Odm-208 More therapies…

    Learn about Your Condition

    Marfan's syndrome Hypophosphatasia Supraventricular tachycardia Glomerulonephritis membranous Coeliac disease Osteosarcoma metastatic Neurodevelopmental disorder Cerebral haemorrhage Oesophageal atresia Athetosis Aortic stenosis Diverticulitis Nodal osteoarthritis Cardiogenic shock Stem cell transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Groupe Hospitalier du Havre – Hôpital Jacques…

Groupe Hospitalier du Havre – Hôpital Jacques Monod

55 B Rue Gustave Flaubert, Montivilliers, 76600, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Landiolol Hydrochloride and Sodium Chloride for Reducing Mortality in Patients with Septic Shock and High Heart Rate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Landiolol Hydrochloride
    • Sodium Chloride
    France

  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Bulgaria Denmark France Germany Greece +6

  • Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    France

  • Safety and efficacy of obinutuzumab in patients with active diffuse systemic sclerosis: a randomized, double-blind, placebo-controlled trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Obinutuzumab
    France

  • Early Saline Pleural Irrigation for Patients with Complicated Pleural Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infectious pleural effusion
    Investigated Drugs:
    • Urokinase
    • Clindamycin Phosphate
    • Cefotaxime
    France

  • Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    France

  • A study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Bimekizumab
    • Adalimumab
    France

  • Study of the effectiveness of iloprost compared to a placebo for treating vaso-occlusive crises in adults with sickle cell disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell anaemia
    Investigated Drugs:
    • ILOPROST
    • Glucose Monohydrate
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Carfilzomib
    • Dexamethasone
    Belgium France

  • A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Bulgaria Denmark France Germany Ireland Italy +3
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!